Independent directory Public ClinicalTrials.gov records United States
Clinical Trials Finder
Objective public record navigation
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Phase 3 Study of Telaprevir in Combination With Pegasys® and Copegus® in Treatment-Naive Subjects With Genotype 1 Hepatitis C Virus (HCV)

ClinicalTrials.gov ID: NCT00627926

Public ClinicalTrials.gov record NCT00627926. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search
ClinicalTrials.gov public records Last synced Sep 2, 2026, 5:52 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Study of 2 Dose Regimens of Telaprevir in Combination With Peginterferon Alfa-2a (Pegasys®) and Ribavirin (Copegus®) in Treatment-Naive Subjects With Genotype 1 Chronic Hepatitis C

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Phase 3 study to evaluate the efficacy and safety of two dosing regimens of telaprevir in combination with pegylated interferon alfa 2a (Peg-IFN-alfa-2a) and ribavirin (RBV).

Study identification

NCT ID
NCT00627926
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
1,095 participants

Conditions and interventions

Conditions

Interventions

Biological · Drug · Other

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 29, 2008
Primary completion
Apr 30, 2010
Completion
Apr 30, 2010
Last update posted
Aug 7, 2014

2008 – 2010

United States locations

U.S. sites
65
U.S. states
24
U.S. cities
51
Facility City State ZIP Site status
Not listed Birmingham Alabama 35209 —
Not listed Birmingham Alabama 35294 —
Not listed Phoenix Arizona 85054 —
Not listed Fresno California 93721 —
Not listed La Jolla California 92037 —
Not listed Long Beach California 90822 —
Not listed Los Angeles California 90033 —
Not listed Los Angeles California 90048 —
Not listed San Diego California 92103 —
Not listed San Diego California 92123 —
Not listed San Diego California 92154 —
Not listed San Francisco California 94115 —
Not listed San Francisco California 94121 —
Not listed San Francisco California 94143 —
Not listed Aurora Colorado 80045 —
Not listed Gainesville Florida 32610 —
Not listed Jacksonville Florida 32224 —
Not listed Jacksonville Florida 32256 —
Not listed Miami Florida 33136 —
Not listed Orlando Florida 32803 —
Not listed Sarasota Florida 34243 —
Not listed South Miami Florida 33143 —
Not listed Atlanta Georgia 30308 —
Not listed Savannah Georgia 31405 —
Not listed Honolulu Hawaii 96817 —
Not listed Chicago Illinois 60637 —
Not listed Carmel Indiana 46032 —
Not listed Indianapolis Indiana 46202 —
Not listed Portland Maine 04102 —
Not listed Baltimore Maryland 21287 —
Not listed Laurel Maryland 20707 —
Not listed Boston Massachusetts 02114 —
Not listed Boston Massachusetts 02215 —
Not listed Worcester Massachusetts 01655 —
Not listed Detroit Michigan 48202 —
Not listed Kansas City Missouri 64131 —
Not listed St Louis Missouri 63104 —
Not listed Omaha Nebraska 68105 —
Not listed Albuquerque New Mexico 87131 —
Not listed Manhasset New York 11030 —
Not listed New York New York 10003 —
Not listed New York New York 10021 —
Not listed New York New York 10029 —
Not listed New York New York 10032 —
Not listed Valhalla New York 10595 —
Not listed Chapel Hill North Carolina 27599 —
Not listed Charlotte North Carolina 28203 —
Not listed Durham North Carolina 27710 —
Not listed Fayetteville North Carolina 28304 —
Not listed Cincinnati Ohio 45219 —
Not listed Cincinnati Ohio 45267 —
Not listed Cleveland Ohio 44195 —
Not listed Hershey Pennsylvania 17033 —
Not listed Philadelphia Pennsylvania 19104 —
Not listed Pittsburgh Pennsylvania 15213 —
Not listed Columbia South Carolina 29204 —
Not listed Germantown Tennessee 38138 —
Not listed Dallas Texas 75203 —
Not listed Dallas Texas 75246 —
Not listed Dallas Texas 75390 —
Not listed Houston Texas 77030 —
Not listed San Antonio Texas 78215 —
Not listed Annandale Virginia 22003 —
Not listed Charlottesville Virginia 22908 —
Not listed Richmond Virginia 23249 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00627926, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 7, 2014 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00627926 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →